Delivery Order SPE2DB22D2206-SPE2DB25FJA50
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,373.47 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under the company's existing contract vehicle with DLA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,366.88 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of May 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,011.68 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Onfil 10 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $7,471.73. This non-set-aside award is classified as a delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical supply requirement within the...
- The Defense Logistics Agency awarded a $4,906.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for 100 tablets of Onfil 10 mg. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,884.13 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with delivery scheduled for completion by September 11, 2025. The contract was awarded on September 10, 2025, under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,638.32 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The delivery order was awarded on August 25, 2025, and represents a single pharmaceutical transaction under AmerisourceBergen's broader federal contracting relationship. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,589.68 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on July 10, 2025, with completion expected by July 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical distributor, headquartered...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA50Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,517.04 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with a firm fixed price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive procurement under AmerisourceBergen Drug Corp's existing pharmaceutical supply framework with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp has demonstrated substantial capability in fulfilling federal medical procurement requirements, serving customers including the Defense Health Agency and U.S. Coast Guard through competitively awarded contracts with firm fixed pricing across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 7/23/25 |